Skip to main content
TipRanks
Go Ultimate75% OFF

BioMarin Pharmaceutical (BM8) Ownership - Who Owns BioMarin Pharmaceutical?

1 Followers

BioMarin Pharmaceutical (BM8) Ownership Overview

  • 0.45% Insiders
  • 32.46% Mutual Funds
  • 35.76% Other Institutional Investors
  • 24.19% ETFs
  • 7.13% Public Companies and Individual Investors

The ownership structure of BioMarin Pharmaceutical (DE:BM8) stock is a mix of institutional, retail, and individual investors. Approximately 92.42% of the company’s stock is owned by Institutional Investors, 0.45% is owned by Insiders, and 7.13% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Recent Insider Trading Activity
DateNameActivityValue
Sep 02, 2026George Eric Davis$1,163,678
May 10, 2026Gregory R Friberg$176,682
Mar 11, 2026Charles Greg Guyer$996,744
Feb 25, 2026Gregory R Friberg$381,901

Recent Hedge Fund Trading Activity

Recent Hedge Fund Trading Activity
DateFirmActivityValue
Dec 31, 2025Entrypoint Capital, Llc€417,733
Dec 31, 2025Hussman Strategic Advisors Inc€1,872,045
Dec 31, 2025Fisher Asset Management Llc€2,097,284
Dec 31, 2025Bridgewater Associates, Lp€13,666,582

Top Shareholders

DE:BM8 top shareholders
Holder# of SharesType% HoldingValue
BlackRock, Inc.20,735,548Institution10.71%1,162,994,681
Vanguard16,599,185Institution8.57%930,998,489
Vanguard Index Funds15,347,055Institution7.92%860,770,274
Theofanis Kolokotrones14,988,996Institution7.74%840,687,819
John A. Gunn14,625,740Institution7.55%820,313,879
Ishares12,796,797Institution6.61%717,733,953
Dodge & Cox Funds11,483,325Institution5.93%644,065,249
Andreas Halvorsen7,616,563Institution3.93%427,190,169
Spdr6,347,870Institution3.28%356,032,985
Vanguard Horizon Funds5,449,401Institution2.81%305,640,554

Top Mutual Fund Holders

DE:BM8 top mutual fund holders
Holder# of SharesType% HoldingValue
Vanguard Index Funds15,347,055Institution7.92%860,770,274
Dodge & Cox Funds11,483,325Institution5.93%644,065,249
Vanguard Horizon Funds5,449,401Institution2.81%305,640,554
Vanguard Chester Funds4,969,450Institution2.57%278,721,542
Fidelity Contrafund3,068,493Institution1.58%172,102,567
Capital World Growth & Income Fund2,576,251Institution1.33%144,494,190
Primecap Odyssey Funds2,385,741Institution1.23%133,809,055
Fidelity Concord Street Trust1,901,053Institution0.98%106,624,360
Dfa Investment Dimensions Group Inc1,622,377Institution0.84%90,994,259
Fidelity Salem Street Trust1,106,222Institution0.57%62,044,673

FAQ

Who Owns BioMarin Pharmaceutical (DE:BM8)?
According to the latest TipRanks data, approximately 92.42% of the company's stock is held by institutional investors, 0.45% is held by insiders, and 7.13% is held by public companies and individual investors.
What percentage of BioMarin Pharmaceutical (DE:BM8) stock is held by institutional investors?
According to the latest TipRanks data, approximately 92.42% of BioMarin Pharmaceutical (DE:BM8) stock is held by institutional investors: 32.46% by mutual funds, 24.19% by ETFs and 35.76% by other institutional investors.
What percentage of BioMarin Pharmaceutical (DE:BM8) stock is held by retail investors?
According to the latest TipRanks data, approximately 7.13% of BioMarin Pharmaceutical (DE:BM8) stock is held by public companies and individual investors.
Who owns the most shares of BioMarin Pharmaceutical (DE:BM8)?
BlackRock, Inc. owns the most shares of BioMarin Pharmaceutical (DE:BM8).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.